Vasospastic Angina
📧 Sign up to get email alerts when something new happens for Vasospastic Angina.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-10FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from ScieGen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS other · 2026-04-09Clinical Trial Update: iCorMicA - Stratified Medicine in Angina [NA]
An update on the iCorMicA trial shows that the study, sponsored by NHS Greater Glasgow and Clyde, is currently recruiting. It investigates s…
-
FDA approval · 2025-11-14FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves the original application for diltiazem hydrochloride (Alembic Pharmaceuticals Limited), a generic product, for use in treating …
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: POLish Registry of CArdioneuroablation and CArdioneuromodulation
Registry entry for the POLish Registry of Cardioneuroablation and Cardioneuromodulation, currently recruiting, exploring autonomic and cardi…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic
A Czech Republic study is evaluating comprehensive coronary physiology in patients with angina and nonobstructive coronary arteries (ANOCA).…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2025-04-16FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for Cardizem CD (diltiazem hydrochloride) by Bausch Health US LLC.
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: The Impact of Vericiguat on Microvascular Function in Patients with Documented Vasospastic Angina Pectoris [Phase 2]
A Phase 2 clinical trial update evaluating the effect of vericiguat on microvascular function in patients with vasospastic angina is not yet…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries [Phase 2, Phase 3]
This Stanford-initiated clinical trial is evaluating a targeted medical therapy for angina and nonobstructive coronary arteries in Phase 2/3…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Immunomodulatory Therapy & VSA
A completed clinical trial update investigates an immunomodulatory therapy for vasospastic angina (VSA). The study is sponsored by Dao Wen W…
-
FDA approval · 2024-10-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic diltiazem hydrochloride under an Original Application (ANDA).
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries [NA]
This report covers a clinical trial evaluating transcutaneous electrical nerve stimulation for angina in patients with non-obstructive coron…
-
FDA approval · 2022-10-06FDA Approved: NIFEDIPINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for nifedipine from Ascend Laboratories, LLC, updating the existing nifedipine product.
-
FDA approval · 2022-05-05FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE — Original Application (Dr. Reddy's Labratories Inc.)
FDA approves Dr. Reddy's Laboratories' generic diltiazem hydrochloride extended-release tablet (ANDA 215775).
-
FDA approval · 2022-03-29FDA Approved: NIFEDIPINE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' Original Application for nifedipine, a calcium channel blocker used to treat hypertension and angina.
-
FDA approval · 2021-07-19FDA Approved: NIFEDIPINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's nifedipine generic through an original ANDA, covering common indications such as hypertension and an…
-
FDA approval · 2018-12-28FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Armas Pharmaceuticals Inc.)
FDA approves Armas Pharmaceuticals' verapamil hydrochloride as an original ANDA generic; standard indications for verapamil HCl include hype…
-
FDA approval · 2018-06-29FDA Approved: NIFEDIPINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for Nifedipine from Zydus Lifesciences Limited, a generic calcium channel blocker used for hypertensio…
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for Verapamil Hydrochloride by Somerset Therapeutics, LLC, enabling a generic version of verapamil…
-
FDA approval · 2018-05-21FDA Approved: NIFEDIPINE — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for nifedipine submitted by Leading Pharma, LLC.
-
FDA approval · 2018-04-26FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for amlodipine besylate submitted by Unichem Pharmaceuticals (USA), Inc., under ANDA 203245. This co…
-
FDA approval · 2018-04-23FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate from Exelan Pharmaceuticals, Inc., approving a generic product.
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's supplemental application for amlodipine besylate, enabling the marketing of a generic version of the antihypertensive/an…
-
FDA approval · 2017-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved Zydus Pharmaceuticals USA's original application for diltiazem hydrochloride as a generic product, enabling its use for the man…
-
CLINICAL_TRIALS withdrawal · 2017-06-15Clinical Trial Update: Statin Therapy In Patients With Vasospastic Angina [Phase 4]
A Phase 4 clinical trial evaluating statin therapy in patients with vasospastic angina has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina [Phase 3]
A Phase 3 therapeutic confirmatory trial evaluating cilostazol for vasospastic angina has completed, assessing its efficacy and safety.